Ranbaxy Laboratories

#71 – Katherine Eban: Widespread fraud in the generic drug industry

Peter Attia MD

India's largest generic drug company, which became the focus of Katherine Eban's investigation due to widespread data fabrication and fraudulent manufacturing practices across its global drug filings.